Updates in Skin Cancer - PracticalDermatology

1-7 of 7

Rethinking Risk in T1a Melanoma with New Data on Age, Prognosis, and Gene Expression Profiling
Rethinking Risk in T1a Melanoma with New Data on Age, Prognosis, and Gene Expression Profiling
Updates in Skin Cancer
Rethinking Risk in T1a Melanoma with New Data on Age, Prognosis, and Gene Expression Profiling
Hamza D. Bhatti, DO, FAAD
Hamza D. Bhatti, DO, FAAD
Evaluating GEP Test Options
Evaluating GEP Test Options
Updates in Skin Cancer
Evaluating GEP Test Options
David G. Cotter, MD, PhD
David G. Cotter, MD, PhD
GEP Testing in Surgical Oncology
GEP Testing in Surgical Oncology
Updates in Skin Cancer
GEP Testing in Surgical Oncology
J. Michael Guenther, MD
J. Michael Guenther, MD
GEP Testing for Cutaneous Squamous Cell Carcinoma
GEP Testing for Cutaneous Squamous Cell Carcinoma
Updates in Skin Cancer
GEP Testing for Cutaneous Squamous Cell Carcinoma
Emily Ruiz, MD, MPH
Emily Ruiz, MD, MPH
Using GEP Test Results to Manage Patients
Using GEP Test Results to Manage Patients
Updates in Skin Cancer
Using GEP Test Results to Manage Patients
Jason Rizzo, MD, PhD
Jason Rizzo, MD, PhD
The Importance and Utility of GEP Testing
The Importance and Utility of GEP Testing
Updates in Skin Cancer
The Importance and Utility of GEP Testing
Hadas Skupsky, MD
Hadas Skupsky, MD
When and How to Use Ancillary Testing
When and How to Use Ancillary Testing
Updates in Skin Cancer
When and How to Use Ancillary Testing
Hadas Skupsky, MD
Hadas Skupsky, MD